270 related articles for article (PubMed ID: 17613755)
1. Multipotent mesenchymal stromal cells and immune tolerance.
Noël D; Djouad F; Bouffi C; Mrugala D; Jorgensen C
Leuk Lymphoma; 2007 Jul; 48(7):1283-9. PubMed ID: 17613755
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases.
Djouad F; Bouffi C; Ghannam S; Noël D; Jorgensen C
Nat Rev Rheumatol; 2009 Jul; 5(7):392-9. PubMed ID: 19568253
[TBL] [Abstract][Full Text] [Related]
3. Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
Bouffi C; Djouad F; Mathieu M; Noël D; Jorgensen C
Rheumatology (Oxford); 2009 Oct; 48(10):1185-9. PubMed ID: 19561159
[TBL] [Abstract][Full Text] [Related]
4. Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks.
Tyndall A; Uccelli A
Bone Marrow Transplant; 2009 Jun; 43(11):821-8. PubMed ID: 19308035
[TBL] [Abstract][Full Text] [Related]
5. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.
Müller I; Kordowich S; Holzwarth C; Isensee G; Lang P; Neunhoeffer F; Dominici M; Greil J; Handgretinger R
Blood Cells Mol Dis; 2008; 40(1):25-32. PubMed ID: 17869550
[TBL] [Abstract][Full Text] [Related]
6. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
Reinders ME; Fibbe WE; Rabelink TJ
Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms.
Nasef A; Ashammakhi N; Fouillard L
Regen Med; 2008 Jul; 3(4):531-46. PubMed ID: 18588475
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive effects of multipotent mesenchymal stromal cells in cultures with different O2 content in the medium.
Gornostaeva AN; Andreeva ER; Andrianova IV; Buravkova LB
Bull Exp Biol Med; 2011 Aug; 151(4):526-9. PubMed ID: 22448382
[TBL] [Abstract][Full Text] [Related]
9. The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives.
Abdallah BM; Kassem M
J Cell Physiol; 2009 Jan; 218(1):9-12. PubMed ID: 18726996
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
Jones BJ; McTaggart SJ
Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive properties of mesenchymal stem cells.
Abumaree M; Al Jumah M; Pace RA; Kalionis B
Stem Cell Rev Rep; 2012 Jun; 8(2):375-92. PubMed ID: 21892603
[TBL] [Abstract][Full Text] [Related]
12. Multipotent mesenchymal stromal cells express FoxP3: a marker for the immunosuppressive capacity?
Sundin M; D'arcy P; Johansson CC; Barrett AJ; Lönnies H; Sundberg B; Nava S; Kiessling R; Mougiakakos D; Le Blanc K
J Immunother; 2011 May; 34(4):336-42. PubMed ID: 21499129
[TBL] [Abstract][Full Text] [Related]
13. Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease.
Bernardo ME; Avanzini MA; Ciccocioppo R; Perotti C; Cometa AM; Moretta A; Marconi M; Valli M; Novara F; Bonetti F; Zuffardi O; Maccario R; Corazza GR; Locatelli F
Cytotherapy; 2009; 11(7):825-36. PubMed ID: 19903096
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
Yi T; Song SU
Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in the context of hematopoietic stem cell transplantation: the emerging role of natural killer cells and mesenchymal stromal cells.
Lankester AC; Ball LM; Lang P; Handgretinger R
Pediatr Clin North Am; 2010 Feb; 57(1):97-121. PubMed ID: 20307714
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory properties of human placental mesenchymal stem/stromal cells.
Abumaree MH; Abomaray FM; Alshabibi MA; AlAskar AS; Kalionis B
Placenta; 2017 Nov; 59():87-95. PubMed ID: 28411943
[TBL] [Abstract][Full Text] [Related]
17. Immune properties of mesenchymal stem cells.
Sotiropoulou PA; Papamichail M
Methods Mol Biol; 2007; 407():225-43. PubMed ID: 18453259
[TBL] [Abstract][Full Text] [Related]
18. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory effects of stem cells.
Wada N; Gronthos S; Bartold PM
Periodontol 2000; 2013 Oct; 63(1):198-216. PubMed ID: 23931061
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells: will they have a role in the clinic?
Devine SM
J Cell Biochem Suppl; 2002; 38():73-9. PubMed ID: 12046853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
